Your browser doesn't support javascript.
loading
Predictors of postpartum glucose metabolism disorders in women with gestational diabetes mellitus.
García-Moreno, Rosa M; Benítez-Valderrama, Pamela; Barquiel, Beatriz; Hillman, Natalia; Herranz, Lucrecia; Pérez-de-Villar, Noemí González.
Afiliação
  • García-Moreno RM; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. Electronic address: rosagarcia2812@gmail.com.
  • Benítez-Valderrama P; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain.
  • Barquiel B; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain.
  • Hillman N; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain.
  • Herranz L; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain.
  • Pérez-de-Villar NG; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain.
Diabetes Metab Syndr ; 16(10): 102629, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36191536
ABSTRACT
BACKGROUND AND

AIMS:

Postpartum glucose metabolism disorders are a common problem in women with gestational diabetes mellitus (GDM). They are often underdiagnosed since many patients do not attend the postpartum screening. This study aims to assess predictors of postpartum glucose metabolism disorders and type 2 diabetes mellitus (T2DM) after GDM. MATERIAL AND

METHODS:

Retrospective study in women with GMD who underwent postpartum screening for glucose metabolism disorders (n = 2688). Logistic regression was used in the statistical analysis.

RESULTS:

24.6% of women had postpartum glucose metabolism disorder. In multivariate analysis, pre-pregnancy body mass index (BMI) 25-30 kg/m2 (OR 1.46, 95%CI 1.05 to 2.02) or BMI ≥30 kg/m2 (OR 2.62, 95%CI 1.72 to 3.96), diagnosis of GDM before 20 weeks of pregnancy (OR 2.33, 95%CI 1.57 to 3.46), fasting plasma glucose after diagnosis of GDM ≥90 mg/dl (OR 2.12, 95%CI 1.50 to 2.98), postprandial glucose ≥100 mg/dl (OR 1.47, 95%CI 1.09 to 2.99), and HbA1c in the third trimester of pregnancy ≥5.3% (2.04, 95%CI, 1.52 to 2.75) were independent predictors for any postpartum glucose metabolism disorder.

CONCLUSION:

postpartum screening for T2DM should be performed in all women with GDM, and it is especially important not to lose follow-up in those with one or more predictive factors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Diabetes Mellitus Tipo 2 Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Diabetes Metab Syndr Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Diabetes Mellitus Tipo 2 Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Diabetes Metab Syndr Ano de publicação: 2022 Tipo de documento: Article